• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Vortioxetine

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO SymbolReferenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
VortioxetineNeurology
CYP2D6
CYP2D6 poor metabolizers
Dosage and Administration, Drug interactions,
Clinical Pharmacology

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling